AVALUN receives CE-IVD mark certification for its LabPad INR product

Nov 5, 2017

Cooperation between Avalun and the Sherbrooke University for "connected patients"

LabPad INR got CE marked this month for patient self-testing following a conformity assessment conducted by BSI Healthcare, a UK based notified body.

While LabPad INR was made available since December 2017 for healthcare professional only, this is a key milestone that will pave our way towards full commercial launch at the beginning of 2018, with an initial focus on the European market.

Further tests are under development, with a focus on cardiovascular diseases application.